 | • レポートコード：QFJ1-3868 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ATPアッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（比色、蛍光、生物発光）、用途別市場規模（疾病検査、汚染検査、創薬＆開発、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ATPアッセイの市場動向 ・企業の競争状況、市場シェア ・ATPアッセイの種類別市場規模と予測2016-2027（比色、蛍光、生物発光） ・ATPアッセイの用途別市場規模と予測2016-2027（疾病検査、汚染検査、創薬＆開発、その他） ・ATPアッセイの北米市場規模2016-2027（アメリカ、カナダ） ・ATPアッセイの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ATPアッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ATPアッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・ATPアッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific, Inc.、Agilent Technologies, Inc.、Merck KGaA、Promega Corporation、Danaher Corporation、Geno Technology, Inc.、PerkinElmer, Inc.、Abcam plc、Lonza Group、Elabscience、Hygiena, LLC、AAT Bioquest、MBL International Corporation、Abnova Corporation、BioThema AB、PromoCell GmbH、Canvax Biotech S.L.、BioVision, Inc.、Biotium、Creative Bioarray） ・結論 |
ATP assays are procedures that can measure cell viability based on detection of ATP. All living cells, including bacteria, can be detected with ATP assays.
Market Analysis and Insights: Global ATP Assays Market
The global ATP Assays market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ATP Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ATP Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ATP Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ATP Assays market.
Global ATP Assays Scope and Market Size
ATP Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ATP Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Colorimetric
Fluorescent
Bioluminescent
Segment by Application
Disease Testing
Contamination Testing
Drug Discovery & Development
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Merck KGaA
Promega Corporation
Danaher Corporation
Geno Technology, Inc.
PerkinElmer, Inc.
Abcam plc
Lonza Group
Elabscience
Hygiena, LLC
AAT Bioquest
MBL International Corporation
Abnova Corporation
BioThema AB
PromoCell GmbH
Canvax Biotech S.L.
BioVision, Inc.
Biotium
Creative Bioarray
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ATP Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Colorimetric
1.2.3 Fluorescent
1.2.4 Bioluminescent
1.3 Market by Application
1.3.1 Global ATP Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Disease Testing
1.3.3 Contamination Testing
1.3.4 Drug Discovery & Development
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global ATP Assays Market Perspective (2016-2027)
2.2 ATP Assays Growth Trends by Regions
2.2.1 ATP Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ATP Assays Historic Market Share by Regions (2016-2021)
2.2.3 ATP Assays Forecasted Market Size by Regions (2022-2027)
2.3 ATP Assays Industry Dynamic
2.3.1 ATP Assays Market Trends
2.3.2 ATP Assays Market Drivers
2.3.3 ATP Assays Market Challenges
2.3.4 ATP Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ATP Assays Players by Revenue
3.1.1 Global Top ATP Assays Players by Revenue (2016-2021)
3.1.2 Global ATP Assays Revenue Market Share by Players (2016-2021)
3.2 Global ATP Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ATP Assays Revenue
3.4 Global ATP Assays Market Concentration Ratio
3.4.1 Global ATP Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ATP Assays Revenue in 2020
3.5 ATP Assays Key Players Head office and Area Served
3.6 Key Players ATP Assays Product Solution and Service
3.7 Date of Enter into ATP Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ATP Assays Breakdown Data by Type
4.1 Global ATP Assays Historic Market Size by Type (2016-2021)
4.2 Global ATP Assays Forecasted Market Size by Type (2022-2027)
5 ATP Assays Breakdown Data by Application
5.1 Global ATP Assays Historic Market Size by Application (2016-2021)
5.2 Global ATP Assays Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America ATP Assays Market Size (2016-2027)
6.2 North America ATP Assays Market Size by Type
6.2.1 North America ATP Assays Market Size by Type (2016-2021)
6.2.2 North America ATP Assays Market Size by Type (2022-2027)
6.2.3 North America ATP Assays Market Size by Type (2016-2027)
6.3 North America ATP Assays Market Size by Application
6.3.1 North America ATP Assays Market Size by Application (2016-2021)
6.3.2 North America ATP Assays Market Size by Application (2022-2027)
6.3.3 North America ATP Assays Market Size by Application (2016-2027)
6.4 North America ATP Assays Market Size by Country
6.4.1 North America ATP Assays Market Size by Country (2016-2021)
6.4.2 North America ATP Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe ATP Assays Market Size (2016-2027)
7.2 Europe ATP Assays Market Size by Type
7.2.1 Europe ATP Assays Market Size by Type (2016-2021)
7.2.2 Europe ATP Assays Market Size by Type (2022-2027)
7.2.3 Europe ATP Assays Market Size by Type (2016-2027)
7.3 Europe ATP Assays Market Size by Application
7.3.1 Europe ATP Assays Market Size by Application (2016-2021)
7.3.2 Europe ATP Assays Market Size by Application (2022-2027)
7.3.3 Europe ATP Assays Market Size by Application (2016-2027)
7.4 Europe ATP Assays Market Size by Country
7.4.1 Europe ATP Assays Market Size by Country (2016-2021)
7.4.2 Europe ATP Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific ATP Assays Market Size (2016-2027)
8.2 Asia-Pacific ATP Assays Market Size by Type
8.2.1 Asia-Pacific ATP Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ATP Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ATP Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific ATP Assays Market Size by Application
8.3.1 Asia-Pacific ATP Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ATP Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ATP Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific ATP Assays Market Size by Region
8.4.1 Asia-Pacific ATP Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ATP Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America ATP Assays Market Size (2016-2027)
9.2 Latin America ATP Assays Market Size by Type
9.2.1 Latin America ATP Assays Market Size by Type (2016-2021)
9.2.2 Latin America ATP Assays Market Size by Type (2022-2027)
9.2.3 Latin America ATP Assays Market Size by Type (2016-2027)
9.3 Latin America ATP Assays Market Size by Application
9.3.1 Latin America ATP Assays Market Size by Application (2016-2021)
9.3.2 Latin America ATP Assays Market Size by Application (2022-2027)
9.3.3 Latin America ATP Assays Market Size by Application (2016-2027)
9.4 Latin America ATP Assays Market Size by Country
9.4.1 Latin America ATP Assays Market Size by Country (2016-2021)
9.4.2 Latin America ATP Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ATP Assays Market Size (2016-2027)
10.2 Middle East & Africa ATP Assays Market Size by Type
10.2.1 Middle East & Africa ATP Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ATP Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ATP Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa ATP Assays Market Size by Application
10.3.1 Middle East & Africa ATP Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ATP Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ATP Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa ATP Assays Market Size by Country
10.4.1 Middle East & Africa ATP Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ATP Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. ATP Assays Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in ATP Assays Business (2016-2021)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. ATP Assays Introduction
11.2.4 Agilent Technologies, Inc. Revenue in ATP Assays Business (2016-2021)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA ATP Assays Introduction
11.3.4 Merck KGaA Revenue in ATP Assays Business (2016-2021)
11.3.5 Merck KGaA Recent Development
11.4 Promega Corporation
11.4.1 Promega Corporation Company Details
11.4.2 Promega Corporation Business Overview
11.4.3 Promega Corporation ATP Assays Introduction
11.4.4 Promega Corporation Revenue in ATP Assays Business (2016-2021)
11.4.5 Promega Corporation Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation ATP Assays Introduction
11.5.4 Danaher Corporation Revenue in ATP Assays Business (2016-2021)
11.5.5 Danaher Corporation Recent Development
11.6 Geno Technology, Inc.
11.6.1 Geno Technology, Inc. Company Details
11.6.2 Geno Technology, Inc. Business Overview
11.6.3 Geno Technology, Inc. ATP Assays Introduction
11.6.4 Geno Technology, Inc. Revenue in ATP Assays Business (2016-2021)
11.6.5 Geno Technology, Inc. Recent Development
11.7 PerkinElmer, Inc.
11.7.1 PerkinElmer, Inc. Company Details
11.7.2 PerkinElmer, Inc. Business Overview
11.7.3 PerkinElmer, Inc. ATP Assays Introduction
11.7.4 PerkinElmer, Inc. Revenue in ATP Assays Business (2016-2021)
11.7.5 PerkinElmer, Inc. Recent Development
11.8 Abcam plc
11.8.1 Abcam plc Company Details
11.8.2 Abcam plc Business Overview
11.8.3 Abcam plc ATP Assays Introduction
11.8.4 Abcam plc Revenue in ATP Assays Business (2016-2021)
11.8.5 Abcam plc Recent Development
11.9 Lonza Group
11.9.1 Lonza Group Company Details
11.9.2 Lonza Group Business Overview
11.9.3 Lonza Group ATP Assays Introduction
11.9.4 Lonza Group Revenue in ATP Assays Business (2016-2021)
11.9.5 Lonza Group Recent Development
11.10 Elabscience
11.10.1 Elabscience Company Details
11.10.2 Elabscience Business Overview
11.10.3 Elabscience ATP Assays Introduction
11.10.4 Elabscience Revenue in ATP Assays Business (2016-2021)
11.10.5 Elabscience Recent Development
11.11 Hygiena, LLC
11.11.1 Hygiena, LLC Company Details
11.11.2 Hygiena, LLC Business Overview
11.11.3 Hygiena, LLC ATP Assays Introduction
11.11.4 Hygiena, LLC Revenue in ATP Assays Business (2016-2021)
11.11.5 Hygiena, LLC Recent Development
11.12 AAT Bioquest
11.12.1 AAT Bioquest Company Details
11.12.2 AAT Bioquest Business Overview
11.12.3 AAT Bioquest ATP Assays Introduction
11.12.4 AAT Bioquest Revenue in ATP Assays Business (2016-2021)
11.12.5 AAT Bioquest Recent Development
11.13 MBL International Corporation
11.13.1 MBL International Corporation Company Details
11.13.2 MBL International Corporation Business Overview
11.13.3 MBL International Corporation ATP Assays Introduction
11.13.4 MBL International Corporation Revenue in ATP Assays Business (2016-2021)
11.13.5 MBL International Corporation Recent Development
11.14 Abnova Corporation
11.14.1 Abnova Corporation Company Details
11.14.2 Abnova Corporation Business Overview
11.14.3 Abnova Corporation ATP Assays Introduction
11.14.4 Abnova Corporation Revenue in ATP Assays Business (2016-2021)
11.14.5 Abnova Corporation Recent Development
11.15 BioThema AB
11.15.1 BioThema AB Company Details
11.15.2 BioThema AB Business Overview
11.15.3 BioThema AB ATP Assays Introduction
11.15.4 BioThema AB Revenue in ATP Assays Business (2016-2021)
11.15.5 BioThema AB Recent Development
11.16 PromoCell GmbH
11.16.1 PromoCell GmbH Company Details
11.16.2 PromoCell GmbH Business Overview
11.16.3 PromoCell GmbH ATP Assays Introduction
11.16.4 PromoCell GmbH Revenue in ATP Assays Business (2016-2021)
11.16.5 PromoCell GmbH Recent Development
11.17 Canvax Biotech S.L.
11.17.1 Canvax Biotech S.L. Company Details
11.17.2 Canvax Biotech S.L. Business Overview
11.17.3 Canvax Biotech S.L. ATP Assays Introduction
11.17.4 Canvax Biotech S.L. Revenue in ATP Assays Business (2016-2021)
11.17.5 Canvax Biotech S.L. Recent Development
11.18 BioVision, Inc.
11.18.1 BioVision, Inc. Company Details
11.18.2 BioVision, Inc. Business Overview
11.18.3 BioVision, Inc. ATP Assays Introduction
11.18.4 BioVision, Inc. Revenue in ATP Assays Business (2016-2021)
11.18.5 BioVision, Inc. Recent Development
11.18 Biotium
.1 Biotium Company Details
.2 Biotium Business Overview
.3 Biotium ATP Assays Introduction
.4 Biotium Revenue in ATP Assays Business (2016-2021)
.5 Biotium Recent Development
11.20 Creative Bioarray
11.20.1 Creative Bioarray Company Details
11.20.2 Creative Bioarray Business Overview
11.20.3 Creative Bioarray ATP Assays Introduction
11.20.4 Creative Bioarray Revenue in ATP Assays Business (2016-2021)
11.20.5 Creative Bioarray Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global ATP Assays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Colorimetric
Table 3. Key Players of Fluorescent
Table 4. Key Players of Bioluminescent
Table 5. Global ATP Assays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global ATP Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global ATP Assays Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global ATP Assays Market Share by Regions (2016-2021)
Table 9. Global ATP Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global ATP Assays Market Share by Regions (2022-2027)
Table 11. ATP Assays Market Trends
Table 12. ATP Assays Market Drivers
Table 13. ATP Assays Market Challenges
Table 14. ATP Assays Market Restraints
Table 15. Global ATP Assays Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global ATP Assays Market Share by Players (2016-2021)
Table 17. Global Top ATP Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ATP Assays as of 2020)
Table 18. Ranking of Global Top ATP Assays Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by ATP Assays Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players ATP Assays Product Solution and Service
Table 22. Date of Enter into ATP Assays Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global ATP Assays Market Size by Type (2016-2021) (US$ Million)
Table 25. Global ATP Assays Revenue Market Share by Type (2016-2021)
Table 26. Global ATP Assays Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global ATP Assays Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global ATP Assays Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global ATP Assays Revenue Market Share by Application (2016-2021)
Table 30. Global ATP Assays Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global ATP Assays Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America ATP Assays Market Size by Type (2016-2021) (US$ Million)
Table 33. North America ATP Assays Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America ATP Assays Market Size by Application (2016-2021) (US$ Million)
Table 35. North America ATP Assays Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America ATP Assays Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America ATP Assays Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe ATP Assays Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe ATP Assays Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe ATP Assays Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe ATP Assays Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe ATP Assays Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe ATP Assays Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific ATP Assays Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific ATP Assays Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific ATP Assays Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific ATP Assays Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific ATP Assays Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific ATP Assays Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America ATP Assays Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America ATP Assays Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America ATP Assays Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America ATP Assays Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America ATP Assays Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America ATP Assays Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa ATP Assays Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa ATP Assays Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa ATP Assays Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa ATP Assays Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa ATP Assays Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa ATP Assays Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific, Inc. Company Details
Table 63. Thermo Fisher Scientific, Inc. Business Overview
Table 64. Thermo Fisher Scientific, Inc. ATP Assays Product
Table 65. Thermo Fisher Scientific, Inc. Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific, Inc. Recent Development
Table 67. Agilent Technologies, Inc. Company Details
Table 68. Agilent Technologies, Inc. Business Overview
Table 69. Agilent Technologies, Inc. ATP Assays Product
Table 70. Agilent Technologies, Inc. Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 71. Agilent Technologies, Inc. Recent Development
Table 72. Merck KGaA Company Details
Table 73. Merck KGaA Business Overview
Table 74. Merck KGaA ATP Assays Product
Table 75. Merck KGaA Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 76. Merck KGaA Recent Development
Table 77. Promega Corporation Company Details
Table 78. Promega Corporation Business Overview
Table 79. Promega Corporation ATP Assays Product
Table 80. Promega Corporation Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 81. Promega Corporation Recent Development
Table 82. Danaher Corporation Company Details
Table 83. Danaher Corporation Business Overview
Table 84. Danaher Corporation ATP Assays Product
Table 85. Danaher Corporation Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 86. Danaher Corporation Recent Development
Table 87. Geno Technology, Inc. Company Details
Table 88. Geno Technology, Inc. Business Overview
Table 89. Geno Technology, Inc. ATP Assays Product
Table 90. Geno Technology, Inc. Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 91. Geno Technology, Inc. Recent Development
Table 92. PerkinElmer, Inc. Company Details
Table 93. PerkinElmer, Inc. Business Overview
Table 94. PerkinElmer, Inc. ATP Assays Product
Table 95. PerkinElmer, Inc. Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 96. PerkinElmer, Inc. Recent Development
Table 97. Abcam plc Company Details
Table 98. Abcam plc Business Overview
Table 99. Abcam plc Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 100. Abcam plc Recent Development
Table 101. Lonza Group Company Details
Table 102. Lonza Group Business Overview
Table 103. Lonza Group ATP Assays Product
Table 104. Lonza Group Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 105. Lonza Group Recent Development
Table 106. Elabscience Company Details
Table 107. Elabscience Business Overview
Table 108. Elabscience ATP Assays Product
Table 109. Elabscience Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 110. Elabscience Recent Development
Table 111. Hygiena, LLC Company Details
Table 112. Hygiena, LLC Business Overview
Table 113. Hygiena, LLC ATP Assays Product
Table 114. Hygiena, LLC Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 115. Hygiena, LLC Recent Development
Table 116. AAT Bioquest Company Details
Table 117. AAT Bioquest Business Overview
Table 118. AAT Bioquest ATP Assays Product
Table 119. AAT Bioquest Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 120. AAT Bioquest Recent Development
Table 121. MBL International Corporation Company Details
Table 122. MBL International Corporation Business Overview
Table 123. MBL International Corporation ATP Assays Product
Table 124. MBL International Corporation Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 125. MBL International Corporation Recent Development
Table 126. Abnova Corporation Company Details
Table 127. Abnova Corporation Business Overview
Table 128. Abnova Corporation ATP Assays Product
Table 129. Abnova Corporation Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 130. Abnova Corporation Recent Development
Table 131. BioThema AB Company Details
Table 132. BioThema AB Business Overview
Table 133. BioThema AB ATP Assays Product
Table 134. BioThema AB Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 135. BioThema AB Recent Development
Table 136. PromoCell GmbH Company Details
Table 137. PromoCell GmbH Business Overview
Table 138. PromoCell GmbH ATP Assays Product
Table 139. PromoCell GmbH Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 140. PromoCell GmbH Recent Development
Table 141. Canvax Biotech S.L. Company Details
Table 142. Canvax Biotech S.L. Business Overview
Table 143. Canvax Biotech S.L. ATP Assays Product
Table 144. Canvax Biotech S.L. Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 145. Canvax Biotech S.L. Recent Development
Table 146. BioVision, Inc. Company Details
Table 147. BioVision, Inc. Business Overview
Table 148. BioVision, Inc. ATP Assays Product
Table 149. BioVision, Inc. Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 150. BioVision, Inc. Recent Development
Table 151. Biotium Company Details
Table 152. Biotium Business Overview
Table 153. Biotium ATP Assays Product
Table 154. Biotium Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 155. Biotium Recent Development
Table 156. Creative Bioarray Company Details
Table 157. Creative Bioarray Business Overview
Table 158. Creative Bioarray ATP Assays Product
Table 159. Creative Bioarray Revenue in ATP Assays Business (2016-2021) & (US$ Million)
Table 160. Creative Bioarray Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ATP Assays Market Share by Type: 2020 VS 2027
Figure 2. Colorimetric Features
Figure 3. Fluorescent Features
Figure 4. Bioluminescent Features
Figure 5. Global ATP Assays Market Share by Application: 2020 VS 2027
Figure 6. Disease Testing Case Studies
Figure 7. Contamination Testing Case Studies
Figure 8. Drug Discovery & Development Case Studies
Figure 9. Other Case Studies
Figure 10. ATP Assays Report Years Considered
Figure 11. Global ATP Assays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global ATP Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global ATP Assays Market Share by Regions: 2020 VS 2027
Figure 14. Global ATP Assays Market Share by Regions (2022-2027)
Figure 15. Global ATP Assays Market Share by Players in 2020
Figure 16. Global Top ATP Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ATP Assays as of 2020
Figure 17. The Top 10 and 5 Players Market Share by ATP Assays Revenue in 2020
Figure 18. Global ATP Assays Revenue Market Share by Type (2016-2021)
Figure 19. Global ATP Assays Revenue Market Share by Type (2022-2027)
Figure 20. North America ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America ATP Assays Market Share by Type (2016-2027)
Figure 22. North America ATP Assays Market Share by Application (2016-2027)
Figure 23. North America ATP Assays Market Share by Country (2016-2027)
Figure 24. United States ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe ATP Assays Market Share by Type (2016-2027)
Figure 28. Europe ATP Assays Market Share by Application (2016-2027)
Figure 29. Europe ATP Assays Market Share by Country (2016-2027)
Figure 30. Germany ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific ATP Assays Market Share by Type (2016-2027)
Figure 38. Asia-Pacific ATP Assays Market Share by Application (2016-2027)
Figure 39. Asia-Pacific ATP Assays Market Share by Region (2016-2027)
Figure 40. China ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America ATP Assays Market Share by Type (2016-2027)
Figure 48. Latin America ATP Assays Market Share by Application (2016-2027)
Figure 49. Latin America ATP Assays Market Share by Country (2016-2027)
Figure 50. Mexico ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa ATP Assays Market Share by Type (2016-2027)
Figure 54. Middle East & Africa ATP Assays Market Share by Application (2016-2027)
Figure 55. Middle East & Africa ATP Assays Market Share by Country (2016-2027)
Figure 56. Turkey ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE ATP Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific, Inc. Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 61. Merck KGaA Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 62. Promega Corporation Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 63. Danaher Corporation Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 64. Geno Technology, Inc. Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 65. PerkinElmer, Inc. Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 66. Abcam plc Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 67. Lonza Group Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 68. Elabscience Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 69. Hygiena, LLC Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 70. AAT Bioquest Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 71. MBL International Corporation Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 72. Abnova Corporation Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 73. BioThema AB Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 74. PromoCell GmbH Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 75. Canvax Biotech S.L. Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 76. BioVision, Inc. Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 77. Biotium Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 78. Creative Bioarray Revenue Growth Rate in ATP Assays Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の免疫腫瘍学アッセイ市場規模・現状・予測（2021年-2027年） Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoin…- 世界のタンパク質ベースマルチプレックスアッセイ市場規模・現状・予測（2021年-2027年） Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect …
- 世界の核酸ベースマルチプレックスアッセイ市場規模・現状・予測（2021年-2027年） Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect …
- 世界のアンチトロンビンIIIテスト市場規模・現状・予測（2021年-2027年） Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system. α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A …
- 世界のレジオネラ症検査市場規模・現状・予測（2021年-2027年） Legionnaires disease is atypical pneumonia caused by legionella bacteria. Market Analysis and Insights: Global Legionnaire Disease Testing Market The global Legionnaire Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021…